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Abstract The effect of AMP-activated protein kinase (AMPK)
in the regulation of the phosphoenolpyruvate carboxykinase
(PEPCK) gene expression was studied in isolated rat hepato-
cytes. Activation of AMPK by AICAR counteracted the
inhibitory effect of glucose on the PEPCK gene expression,
both at the mRNA and the transcriptional levels. It is proposed
that a target for AMPK is involved in the inhibitory effect of
glucose on PEPCK gene transcription. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
The AMP-activated protein kinase (AMPK) is the mamma-
lian homolog of the yeast Snf1 protein kinase which is in-
volved in derepression of glucose-repressed genes (for review,
see [1]). Recently, AMPK has been shown to inhibit the tran-
scriptional activation by glucose of three positively regulated
genes, namely L-type pyruvate kinase [2], spot 14 [2] and fatty
acid synthase [2,3] genes in rat hepatocytes. In opposite, glu-
cose has been reported to negatively regulate the expression of
the phosphoenolpyruvate carboxykinase (PEPCK) gene at a
transcriptional level [4,5]. It may therefore be speculated that,
by analogy to its e¡ect on the genes positively regulated by
glucose, AMPK might also oppose to the inhibitory e¡ect of
glucose on the PEPCK gene expression. This work was there-
fore undertaken to specify whether AMPK activation may
(i) regulate the expression of the PEPCK gene and (ii) inhibit
the transcriptional e¡ect of glucose on the gene in rat hepa-
tocytes. To this end, 5-aminoimidazole-4-carboxamide-1-L-D-
ribofuranoside (AICAR), a speci¢c activator of AMPK activ-
ity [6], was used in isolated hepatocytes. The obtained results
demonstrate that AMPK is involved in the regulation by glu-
cose of the PEPCK gene expression.
2. Materials and methods
2.1. Materials
AICAR and K-amanitin were purchased from Sigma. Guanidium
thiocyanate was from Fluka (Basel, Switzerland). [K-32P]dCTP (spe-
ci¢c activity 3000 Ci/mmol), [K-32P]dUTP (speci¢c activity 800 Ci/
mmol), [Q-32P]ATP (speci¢c activity 500 Ci/mmol), Hybond-N mem-
branes, multiprime DNA labelling kit and Hyper¢lm MP were from
Amersham.
The probes and plasmids used were an insert of rat PEPCK cDNA
provided by Dr. R.W. Hanson [7], an insert of rat glyceraldehyde-3-
phosphate dehydrogenase (GraP-DH) cDNA provided by Dr. J.M.
Blanchard [8] and a plasmid containing the 18S rRNA insert provided
by Dr. A. Mazur (INRA, Clermont Ferrand, France).
2.2. Incubation of hepatocytes
Hepatocytes were prepared as described previously [9] from 24 h
starved male Wistar rats (180^220 g). The cells (usually 50^70 mg wet
weight/ml) were shaken (165 strokes/min) in stoppered scintillation
vials at 37‡C for the indicated times. The standard incubation medium
was a Krebs^Henseleit bicarbonate bu¡er at pH 7.4. For RNA deter-
mination, the cells were spun down rapidly at 4‡C (2000Ug, 30 s) at
the end of the incubation period and the pellets stored at 380‡C.
2.3. Extraction and analysis of RNA
Isolation of total RNA was performed by a guanidium thiocyanate
procedure [10]. RNA was separated on 1.5% agarose/formaldehyde
gels and transferred to nylon membrane for Northern hybridization.
Membranes were hybridized using random oligonucleotide-primed
32P-labelled insert as described [11] and they were washed and exposed
to Hyper¢lm at 380‡C, using intensifying screens. Relative densities
of the hybridization signals were quanti¢ed by densitometric scanning.
To correct for di¡erences in RNA loading, all the results were ex-
pressed as the ratio of the scanned values for PEPCK mRNA versus
those for GraP-DH mRNA (relative level).
2.4. Nuclear run-on transcription assay
The preparation of nuclei and the RNA-polymerase elongation re-
action were performed essentially as described [12]. For transcription,
8U106 nuclei were incubated for 30 min at 28‡C in 200 Wl 15%
glycerol, 50 mM HEPES pH 8.0, 150 mM KCl, 1 mM dithiothreitol,
2.5 mM magnesium acetate, 1 mM MnCl2, 0.5 mM EDTA, 4 mM
creatine phosphate, 15 U/ml creatine kinase, 1 mM spermidine, 0.5
mM each of ATP, CTP and GTP, and 500 U/ml RNasin, in the
presence of 100 WCi of [K-32P]dUTP. DNase I (40 U) was added
and the samples were incubated at 37‡C for 15 min. The labelled
RNAs were extracted as described [10]. Denatured plasmids (5 Wg)
were spotted onto cellulose using a slot blot apparatus. Each DNA
bearing ¢lters was prehybridized then hybridized with labelled RNA
(5U106 cpm) at 42‡C for 3 days. Hybridization was carried out with
three separate plasmids: the PEPCK cDNA, a non-recombinant pUC
plasmid as a control for non-speci¢c binding of labelled RNA, and
the 18S rRNA probe as internal control. Filters were washed and
exposed to Hyper¢lm at 580‡C with intensifying screens. The relative
amount of labelled transcripts hybridized to plasmids was determined
by densitometric scanning of autoradiograms. The values obtained for
the PEPCK signal were corrected using the 18S values.
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2.5. Measurement of AMPK activity
Cytosolic extracts were prepared as described by Forest et al. [3],
including the PEG step. Aliquots (5 Wl) were used to measure the
AMPK activity by the SAMS peptide phosphorylation assay in the
presence of 200 WM 5P-AMP, as described by Davies et al. [13] (25 Wl
¢nal assay volume). AMP kinase activity is expressed as nmol of
phosphate incorporated into SAMS peptide/min/mg protein (U/mg
protein).
2.6. Expression of results
Results are expressed as means þ S.E.M. for the observations on the
indicated number (n) of di¡erent cell preparations. Statistical signi¢-
cance of di¡erences was calculated by the Student’s t-test for paired
data.
3. Results and discussion
3.1. AICAR maintained the PEPCK mRNA level
Hepatocytes were incubated for 120 min in the presence of
5 mM glucose with or without 500 WM AICAR. AICAR
addition induced a signi¢cant increase in the PEPCK
mRNA level : 0.57 þ 0.08, control; 1.73 þ 0.38, +500 WM AI-
CAR; n = 7; P6 0.05. The half-maximum e¡ect was observed
at about 150 WM AICAR (Fig. 1). In order to specify the
modalities of action of AICAR, we studied the time-course
of the e¡ect of AICAR. Hepatocytes were incubated with or
without 500 WM AICAR for various periods of time, as in-
dicated, and the PEPCK mRNA level was measured. The
obtained results showed that, ¢rstly, the PEPCK mRNA level
decreased after the ¢rst hour of the incubation period in con-
trol cells and, secondly, AICAR addition maintained the
PEPCK mRNA level to its initial value throughout the experi-
ment (Fig. 2). This demonstrated that the main e¡ect of AI-
CAR was to maintain the PEPCK mRNA level to its initial
value. Since AICAR is known to induce an increase in the
AMPK activity, this suggested that the e¡ect on the PEPCK
mRNA might be a consequence of AMPK activation. We
therefore studied the possible relationship between AMPK
activation and PEPCK gene expression.
3.2. AMPK activation is responsible for the e¡ect of AICAR
on the PEPCK gene expression
We ¢rst studied the time-course of the kinase activation
under the in£uence of AICAR. Hepatocytes were incubated
in the presence of 5 mM glucose with or without 500 WM
AICAR for various periods of time, as indicated. As shown
in Fig. 3, AICAR activated AMPK in the ¢rst minutes of the
incubation period and this e¡ect was maximal between 10 and
15 min. To study the possible relationship between AMPK
activity and PEPCK mRNA level, hepatocytes were therefore
incubated in the presence of 5 mM glucose with various con-
centrations of AICAR, and AMPK activity and PEPCK
mRNA level were measured at 15 min and 120 min, respec-
tively. As shown in Fig. 4, AICAR dose-dependently in-
creased the PEPCK mRNA level and a close relationship
may be established between PEPCK mRNA level and
APMK activity. This strongly suggested that the observed
e¡ect of AICAR on the PEPCK mRNA level might be a
consequence of AMPK activation. In order to specify this
point, AMPK activation was induced by incubating the cells
without O2. As expected, hypoxia induced an increase in the
AMPK activity as measured after 15 min of incubation
Fig. 1. Dose-response of the e¡ect of AICAR on the PEPCK
mRNA level. Hepatocytes were incubated for 120 min with 5 mM
glucose in the presence of various concentrations of AICAR, as in-
dicated. Total RNA was extracted and 20 Wg aliquots analyzed by
Northern blot. They were probed successively with the PEPCK and
the GraP-DH cDNAs. A: Representative autoradiogram. B:
Scanned data of autoradiograms. Values are expressed as means
þ S.E.M. for ¢ve di¡erent cell preparations. *: signi¢cantly di¡erent
(P6 0.05) from the control value.
Fig. 2. Time-course study of the e¡ect of AICAR on the PEPCK
mRNA level. Hepatocytes were incubated with 5 mM glucose in the
absence (b) or in the presence of 500 WM AICAR (a) for various
periods of time, as indicated. Total RNA was extracted and 20 Wg
aliquots analyzed by Northern blot. They were probed successively
with the PEPCK and the GraP-DH cDNAs. A: Representative
autoradiogram. B: Scanned data of autoradiograms. Values are ex-
pressed as means þ S.E.M. for ¢ve di¡erent cell preparations. *: sig-
ni¢cantly di¡erent (P6 0.05) from the corresponding control value.
$: signi¢cantly di¡erent (P6 0.05) from the 0 min value.
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(1.43 þ 0.30 U/mg protein, control ; 2.15 þ 0.36* U/mg protein,
no O2) and this was associated with an increase in the PEPCK
mRNA level at the end of the experiment (i.e. 120 min)
(100%, control ; 242.9 þ 34.8%*, no O2 ; n = 3; P6 0.05).
This demonstrated that AMPK activation was responsible
for the e¡ect of AICAR on the PEPCK mRNA level.
3.3. AMPK activation acts at a transcriptional level
In order to specify whether a transcriptional mechanism
was involved, run-on transcription assays were performed.
Hepatocytes were incubated for 100 min in the presence of
5 mM glucose with or without 250 WM AICAR. As shown in
Fig. 5 for a representative experiment, AICAR addition in-
duced an increase in the rate of transcription of the PEPCK
gene (1, control; 1.76 þ 0.18, +AICAR; n = 4; P6 0.05).
Moreover, this ¢gure also shows that such an increase (1,
control ; 2.04, without O2 ; n = 2) was observed in cells incu-
bated without O2, a condition known to activate AMPK (vide
supra). This demonstrated that AMPK activation acts at a
transcriptional level. Glucose has been reported to decrease
the rate of transcription of the PEPCK gene in both isolated
[4] and cultured rat hepatocytes [5]. Moreover, we showed
that the PEPCK mRNA level decreased in the presence of
5 mM glucose (control cells) but AMPK activation main-
tained the level at the initial value (Fig. 2). Taken together,
these results therefore suggested that AMPK activation might
counteract the transcriptional inhibitory e¡ect of glucose on
the gene. To specify this point, we compared the rate of tran-
scription of the gene in hepatocytes incubated for 10 and
100 min, respectively, in the presence of 5 mM glucose both
with or without 250 WM AICAR. The obtained results showed
that glucose induced a decrease of about 50% in the rate of
transcription of the PEPCK gene (1, 10 min; 0.45, 100 min)
but AICAR addition maintained the rate of transcription of
the gene at its initial value (1, 10 min; 1.20, 100 min). Such a
result was obtained in two independent experiments con¢rm-
ing that glucose per se decreases PEPCK gene transcription
and demonstrating that AMPK activation was able to coun-
teract the transcriptional inhibitory e¡ect of glucose on the
PEPCK gene. Although we were not able to measure any
change in the PEPCK mRNA stability using 0.5 Wg/ml K-
amanitin (data not shown), we cannot exclude a post-tran-
scriptional e¡ect of AICAR.
In cultured hepatocytes, Leclerc et al. [2] reported that
PEPCK mRNA level was not modi¢ed by AICAR addition,
in contrast with the present results. The very di¡erent condi-
tions of hepatocytes culture (no glucose and presence of
cAMP, a potent inducer of PEPCK gene expression) may
probably explain this discrepancy.
4. Conclusion
In conclusion, the data reported here demonstrated that
AMPK activation, ¢rstly, was able to oppose to the inhibitory
e¡ect of glucose on the PEPCK gene expression and, sec-
ondly, acted at a transcriptional level. Since AMPK has
been reported to inhibit the transcriptional activation by glu-
cose of positively regulated genes [2,3], it may therefore be
proposed that a target for AMPK was involved in both the
Fig. 5. In£uence of AICAR and hypoxia on the rate of transcrip-
tion of the PEPCK gene. Hepatocytes were incubated for 100 min
with 5 mM glucose in the absence (control) or in the presence of
250 WM AICAR, or without O2. After extraction, nuclei were incu-
bated with [K-32P]UTP, as described. The labelled RNAs were hy-
bridized on to ¢lters containing the PEPCK cDNA, a plasmid pUC
for non-speci¢c binding and the 18S rRNA probe as internal con-
trol.
Fig. 4. Correlation between the AMP kinase activity and the
PEPCK mRNA level. Hepatocytes were incubated for 15 min
(AMPK) and 120 min (mRNA), respectively, with 5 mM glucose in
the presence of various concentrations of AICAR (0, 50, 100, 250
or 500 WM). Values are expressed as means þ S.E.M. for four di¡er-
ent cell preparations. Correlation coe⁄cient = 0.91.
Fig. 3. Time-course study of the e¡ect of AICAR on the AMP ki-
nase activity. Hepatocytes were incubated with 5 mM glucose in the
absence (b) or in the presence of 500 WM AICAR (a) for various
periods of time, as indicated. Cells were collected and AMPK assay
was performed as described. Values are expressed as means þ S.E.M.
for four di¡erent cell preparations, except for 30 min (n = 2). *: sig-
ni¢cantly di¡erent (P6 0.05) from the 0 min value.
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stimulatory and the inhibitory e¡ects of glucose on gene tran-
scription, at least in rat hepatocytes. However, the target in-
volved remains to be identi¢ed.
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